PharmaTher Holdings Ltd. (PHRM.CN)
CAD 0.22
(10.26%)
CAD 0.22
(10.26%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 252.9 Thousand CAD | -71.66% |
| 2022 | 892.47 Thousand CAD | 170.19% |
| 2021 | 330.31 Thousand CAD | -8.51% |
| 2020 | 361.06 Thousand CAD | 3259.32% |
| 2019 | 10.74 Thousand CAD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 245.66 Thousand CAD | -2.86% |
| 2023 Q1 | 802.66 Thousand CAD | -10.06% |
| 2023 Q3 | 251.7 Thousand CAD | -53.89% |
| 2023 Q4 | 252.9 Thousand CAD | 0.48% |
| 2023 Q2 | 545.82 Thousand CAD | -32.0% |
| 2022 FY | 892.47 Thousand CAD | 170.19% |
| 2022 Q2 | 325.63 Thousand CAD | 124.57% |
| 2022 Q1 | 145 Thousand CAD | -56.1% |
| 2022 Q4 | 892.47 Thousand CAD | 58.45% |
| 2022 Q3 | 563.25 Thousand CAD | 72.97% |
| 2021 Q3 | 368.53 Thousand CAD | -25.23% |
| 2021 Q4 | 330.31 Thousand CAD | -10.37% |
| 2021 Q2 | 492.9 Thousand CAD | 52.52% |
| 2021 Q1 | 323.17 Thousand CAD | -10.49% |
| 2021 FY | 330.31 Thousand CAD | -8.51% |
| 2020 Q4 | 361.06 Thousand CAD | -75.26% |
| 2020 FY | 361.06 Thousand CAD | 3259.32% |
| 2020 Q3 | 1.45 Million CAD | 478.26% |
| 2020 Q1 | 339.57 Thousand CAD | 0.0% |
| 2020 Q2 | 252.37 Thousand CAD | -25.68% |
| 2019 FY | 10.74 Thousand CAD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | 2.71 Million CAD | 90.701% |
| Asep Medical Holdings Inc | 3.05 Million CAD | 91.713% |
| BetterLife Pharma Inc. | 8.02 Million CAD | 96.847% |
| BioVaxys Technology Corp. | 3.48 Million CAD | 92.744% |
| ChitogenX Inc. | 6.71 Million CAD | 96.232% |
| Rapid Dose Therapeutics Corp. | 5.04 Million CAD | 94.985% |
| Defence Therapeutics Inc. | 4.06 Million CAD | 93.774% |
| Entheon Biomedical Corp. | 85.32 Thousand CAD | -196.394% |
| Gemina Laboratories Ltd. | 3.04 Million CAD | 91.685% |
| Glow Lifetech Corp. | 2.34 Million CAD | 89.221% |
| Lexston Life Sciences Corp. | 39.86 Thousand CAD | -534.33% |
| Pharmala Biotech Holdings Inc. | 1.02 Million CAD | 75.423% |
| Doseology Sciences Inc. | 82.49 Thousand CAD | -206.576% |
| MYND Life Sciences Inc. | 5.77 Million CAD | 95.621% |
| Nova Mentis Life Science Corp. | 841.66 Thousand CAD | 69.952% |
| PreveCeutical Medical Inc. | 5.95 Million CAD | 95.756% |
| Telescope Innovations Corp. | 1.35 Million CAD | 81.281% |